Queen Mary University of London clinical trial pipeline

8 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 5 with minor changes only.

1. Notable

   Barts Revascularisation Registry

   Primary and study completion pushed from Mar 1, 2026 to Mar 30, 2030

   Queen Mary University of London·Not specified· NCT05255705· Registry history of NCT05255705 on ClinicalTrials.gov (opens the registry)

   Updated Oct 5, 2026

2. Notable

   IPD on Lateral Bone Augmentation

   Recruitment opened

   Queen Mary University of London·Not applicable· NCT06999915· Registry history of NCT06999915 on ClinicalTrials.gov (opens the registry)

   Updated Sep 23, 2026

3. Notable

   DIRECT · Delivery and Implementation of a Randomised Crossover…DIRECT · Delivery and Implementation of a Randomised Crossover Trial on Thrombosis

   Recruitment opened

   Queen Mary University of London·Not applicable· NCT06937372· Registry history of NCT06937372 on ClinicalTrials.gov (opens the registry)

   Updated Sep 23, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.